Hap Trading, LLC Esperion Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 12, 2022	SELL	$3.34 - $5.56 $71,476 - $118,983	-21,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $10,101 - $25,032	2,100 Added 10.88%	21,400 $381,000
Q3 2021 Nov 10, 2021	BUY	$11.34 - $21.37 $29,484 - $55,562	2,600 Added 15.57%	19,300 $266,000
Q2 2021 Aug 11, 2021	BUY	$19.4 - $28.71 $31,039 - $45,936	1,600 Added 10.6%	16,700 $164,000
Q1 2021 May 14, 2021	BUY	$25.12 - $36.89 $379,312 - $557,039	15,100 New	15,100 $108,000
Q2 2019 Aug 14, 2019	SELL	$40.1 - $52.33 $930,320 - $1.21 Million	-23,200 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$40.11 - $53.57 $6.31 Million - $8.43 Million	-157,300 Reduced 87.15%	23,200 $41,000
Q4 2018 Feb 12, 2019	SELL	$36.99 - $59.11 $1.12 Million - $1.79 Million	-30,300 Reduced 14.37%	180,500 $8,000
Q3 2018 Nov 09, 2018	BUY	$40.74 - $51.41 $896,280 - $1.13 Million	22,000 Added 11.65%	210,800 $366,000
Q2 2018 Aug 13, 2018	BUY	$36.2 - $76.4 $532,140 - $1.12 Million	14,700 Added 8.44%	188,800 $590,000
Q1 2018 May 11, 2018	BUY	$65.94 - $80.76 $11.5 Million - $14.1 Million	174,100 New	174,100 $195,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $156M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.